158 related articles for article (PubMed ID: 33347474)
21. Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.
Bar-Zeev N; Kapanda L; King C; Beard J; Phiri T; Mvula H; Crampin AC; Mwansambo C; Costello A; Parashar U; Tate JE; Verani JR; Whitney CG; Heyderman RS; Cunliffe NA; French N;
Vaccine; 2015 May; 33(23):2637-45. PubMed ID: 25917672
[TBL] [Abstract][Full Text] [Related]
22. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).
Meiring S; Cohen C; Quan V; de Gouveia L; Feldman C; Karstaedt A; Klugman KP; Madhi SA; Rabie H; Sriruttan C; von Gottberg A;
PLoS One; 2016; 11(2):e0149104. PubMed ID: 26863135
[TBL] [Abstract][Full Text] [Related]
23. Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.
Jimbo Sotomayor R; Toscano CM; Sánchez Choez X; Vilema Ortíz M; Rivas Condo J; Ghisays G; Haneuse S; Weinberger DM; McGee G; de Oliveira LH
Vaccine; 2020 Oct; 38(45):7033-7039. PubMed ID: 32981782
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.
Diaz J; Terrazas S; Bierrenbach AL; Toscano CM; Alencar GP; Alvarez A; Valenzuela MT; Andrus J; del Aguila R; Hormazábal JC; Araya P; Pidal P; Matus CR; de Oliveira LH
PLoS One; 2016; 11(4):e0153141. PubMed ID: 27058873
[TBL] [Abstract][Full Text] [Related]
25. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
Tsaban G; Ben-Shimol S
Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971
[TBL] [Abstract][Full Text] [Related]
26. Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable
Bhavsar A; Zaryczański J; Wasilewska A; Saragoussi D; Devadiga R; Colby C; Bahar E; Wysocki J
Hum Vaccin Immunother; 2022 Nov; 18(6):2128566. PubMed ID: 36239615
[TBL] [Abstract][Full Text] [Related]
27. Pneumococcal conjugate vaccines in the prevention of childhood pneumonia.
Ivády B
Acta Microbiol Immunol Hung; 2010 Mar; 57(1):1-13. PubMed ID: 20350875
[TBL] [Abstract][Full Text] [Related]
28. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
Li ST; Tancredi DJ
Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
30. Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years-Zimbabwe, 2010-2016.
Dondo V; Mujuru H; Nathoo K; Jacha V; Tapfumanei O; Chirisa P; Manangazira P; Macharaga J; de Gouveia L; Mwenda JM; Katsande R; Weldegebriel G; Pondo T; Matanock A; Lessa FC
Clin Infect Dis; 2019 Sep; 69(Suppl 2):S72-S80. PubMed ID: 31505631
[TBL] [Abstract][Full Text] [Related]
31. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Meningitis and Pneumonia Hospitalizations in Children aged <5 Years in Senegal, 2010-2016.
Faye PM; Sonko MA; Diop A; Thiongane A; Ba ID; Spiller M; Ndiaye O; Dieye B; Mwenda JM; Sow AI; Diop B; Diallo A; Farrar JL
Clin Infect Dis; 2019 Sep; 69(Suppl 2):S66-S71. PubMed ID: 31505625
[TBL] [Abstract][Full Text] [Related]
32. Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
Nzenze SA; Madhi SA; Shiri T; Klugman KP; de Gouveia L; Moore DP; Karstaedt AS; Tempia S; Nunes MC; von Gottberg A
Am J Epidemiol; 2017 Aug; 186(4):435-444. PubMed ID: 28482004
[TBL] [Abstract][Full Text] [Related]
33. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
[TBL] [Abstract][Full Text] [Related]
34. Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa.
Madhi SA; Moreira M; Koen A; van Niekerk N; de Gouveia L; Jose L; Cutland CL; François N; Schoonbroodt S; Ruiz-Guiñazú J; Yarzabal JP; Borys D; Schuerman L
Vaccine; 2020 Feb; 38(10):2350-2360. PubMed ID: 32035706
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
Gastañaduy PA; Steenhoff AP; Mokomane M; Esona MD; Bowen MD; Jibril H; Pernica JM; Mazhani L; Smieja M; Tate JE; Parashar UD; Goldfarb DM
Clin Infect Dis; 2016 May; 62 Suppl 2():S161-7. PubMed ID: 27059351
[TBL] [Abstract][Full Text] [Related]
36. Pneumococcal conjugate vaccine--a health priority.
Zar HJ; Madhi SA
S Afr Med J; 2008 Jun; 98(6):463-7. PubMed ID: 18683380
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines.
Wondimu A; Cao Q; Wilschut JC; Postma MJ
BMC Public Health; 2019 Dec; 19(1):1656. PubMed ID: 31823756
[TBL] [Abstract][Full Text] [Related]
38. Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia.
Mpabalwani EM; Simwaka CJ; Mwenda JM; Mubanga CP; Monze M; Matapo B; Parashar UD; Tate JE
Clin Infect Dis; 2016 May; 62 Suppl 2():S183-7. PubMed ID: 27059354
[TBL] [Abstract][Full Text] [Related]
39. A qualitative study on knowledge, perceptions, and attitudes of mothers and health care providers toward pneumococcal conjugate vaccine in Bandung, West Java, Indonesia.
Harjaningrum AT; Kartasasmita C; Orne-Gliemann J; Jutand MA; Goujon N; Koeck JL
Vaccine; 2013 Mar; 31(11):1516-22. PubMed ID: 23318150
[TBL] [Abstract][Full Text] [Related]
40. The impact of implementing the 10-valent pneumococcal conjugate vaccine on hospitalizations for pneumonia among children.
de Melo Araujo AC; da Silva Aragão J; de Souza WV; Rodrigues LC; de Barros Miranda-Filho D
Vaccine; 2023 Jul; 41(32):4719-4725. PubMed ID: 37353456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
